2162.HK · KEYMED BIO-B
Hong Kong · RS rating 70 · As of 2026-10-14
| Price | 77.15 HKD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 75 / 38 / 71 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 43 / 60 / 34 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +11.5% |
| Market cap (USD) | $2.9B |